Kairos Pharma Approved to Dual List on Upstream

TipRanksNov 19 08:46 ET

Express News | Kairos Pharma Ltd: Announced Its Approval to Dual List Its Shares on Upstream

ReutersNov 19 08:31 ET

Kairos Pharma Price Target Maintained With a $9.00/Share by D. Boral Capital

Dow JonesNov 14 17:06 ET · Ratings

Kairos Pharma Is Maintained at Buy by D. Boral Capital

Dow JonesNov 14 17:06 ET · Ratings

Kairos Pharma | 10-Q: Q3 2024 Earnings Report

SECNov 14 14:21 ET · Announcements

Why Rocket Lab Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket

BenzingaNov 13 05:14 ET